H. Murat et al.: Radioprotection 2025, 60( 1), 65 – 75 75
Salah H, Mayhoub FH, Sulieman A, Abuzaid M, Al-Mohammed HI, Alkhorayef M, Bradley DA. 2020. Fluoro-D-glucose( 18F-FDG) PET / CT and patient effective dose. Radiat Phys Chem 173: 108926.
Sprinz C, Zanon M, Altmayer S, Watte G, Irion K, Marchiori E, Hochhegger B. 2018. Effect s of blood glucose level on 18F fluorodeoxyglucose( 18F-FDG) uptake for PET / CT in normal organs: an analysis on 5623 patients. Sci Rep 8: 6 – 11.
Velo P, Ismail MI, Mohandas KK, Kasilingam L. 2023. A new upper limit for effective dose in patient administered with 18F-FDG for PET / CT whole-body imaging with diagnostic CT parameters. J Med Imag Radiat Sci 54( 1): 43 – 50.
Cite this article as: Murat H, Kechik MMA, Chew MT, Kamal I, Said MA, Karim MKA. 2025. Assessment of lifetime attributable risk( LAR) of cancer incidence from whole-body 18 F-FDG PET / CT examinations using established polynomial fittings. Radioprotection 60( 1): 65 – 75. https:// doi. org / 10.1051 / radiopro / 2024034
Please help to maintain this journal in open access!
This journal is currently published in open access under the Subscribe to Open model( S2O). We are thankful to our subscribers and supporters for making it possible to publish this journal in open access in the current year, free of charge for authors and readers.
Check with your library that it subscribes to the journal, or consider making a personal donation to the S2O programme by contacting subscribers @ edpsciences. org.
More information, including a list of supporters and financial transparency reports, is available at https:// edpsciences. org / en / subscribe-to-open-s2o.